These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1805696)

  • 1. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparative pharmacokinetics of ceftriaxone in the blood and bronchial secretion in patients with different durations in the course of chronic bronchitis].
    Kamnev IuV; Manuĭlov KK; Orlov VA
    Antibiot Khimioter; 1991 Jun; 36(6):48-50. PubMed ID: 1898191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of cefodizime in bronchial secretions after single intravenous administration.
    Pacheco Y; Pirollet B; Taviot B; Coppere B; Perrin-Fayolle M; Dagrosa EE; Damm D
    Arzneimittelforschung; 1993 Aug; 43(8):924-6. PubMed ID: 8216455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue.
    Braga PC; Pozzato C; Cedrini C; Fraschini F; Scarpazza G; Scaglione F; Gagliardi V; Apicella F; Manganelli V; Paiola G
    Clin Ther; 1982; 5(1):69-78. PubMed ID: 6290066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA
    Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gender on the disposition of cefotaxime and desacetylcefotaxime.
    Guay DR; Matzke GR; Heim KL; Halstenson CE; Abraham PA; Keane WF
    Ther Drug Monit; 1987 Sep; 9(3):259-62. PubMed ID: 3672567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1984 Dec; 14(6):653-60. PubMed ID: 6097574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Jul; 19(7):743-54. PubMed ID: 2773510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Dtsch Tierarztl Wochenschr; 1990 Aug; 97(8):324-7. PubMed ID: 2209455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.
    Ko RJ; Sattler FR; Nichols S; Akriviadis E; Runyon B; Appleman M; Cohen JL; Koda RT
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1376-80. PubMed ID: 1929296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; van den Bergh JJ; Costongs RJ; Geraedts WH; Gubbelmans HL; Meek JC
    Infection; 1992; 20 Suppl 1():S22-5. PubMed ID: 1526671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.